North America Synthetic Opioids Market, By Product Type (Synthetic Opioids (Methadone, Fentanyl, and Meperidine), and Semi Synthetic Opioids (Hydrocodane, Oxymorphone, Oxycodone, Hydromorphone, and Buprenorphine)), By Application (Pain Management and De-Addiction), By Distribution Channel (Retail Outlets and Hospitals), and By Country (U.S. and Canada)-

Published In : Jun 2023

Code : CMI3660

Pages :151

Formats :

Excel and PDF

Industry : Pharmaceutical

Market Challenges And Opportunities

North America Synthetic Opioids Market – Driver

Lauching New Strategy By Government Organizations

Increasing launches of new strategy by government organization, in order to prevent global crisis of synthetic opioids is expected to drive the market growth over the forecast period. For instance, in November 2021, United Nations Office on Drugs and Crime (UNODC), a government organization, launched a new strategy to prevent global crisis of synthetic opioids. This new strategy will help policymakers to introduce effective policy directions and strategies, and to provide access to treatment in different parts of the world. This strategy will also help to introduce new policy directions to interrupt the manufacture and trafficking of synthetic drugs.

North America Synthetic Opioids Market: Restraint

Increasing Side Effects Due To Overdose of Opioids

The North America synthetic opioids market can be hindered by increasing side effects due to over dose of opioids. For instance, according to the data published in June 2022, by Centers for Disease Control and Prevention, in the U.S., deaths from synthetic opioids (other than methadone) accounted for more than 56,000 fatalities in 2020, more than any other class of opioid. Over 82% of all opioid-related deaths in 2020 were caused by synthetic opioids, death rates were increased by over 56% between 2019 and 2020.